Advancing science, assessing long-term performance
As a national leader in implantable pain management systems, Nura physicians and researchers often work with medical device companies to study the long-term performance of specific devices.
Nura Research Studies
Safety of Interlaminar Cervical Epidural Injections: Experience With 12,168 Procedures in a Single Pain Clinic as seen in Pain Physician Journal
Patient Satisfaction Following Intrathecal Targeted Drug Delivery for Benign Chronic Pain: Results of a Single-Center Survey Study as seen in Neuromodulation Journal
Targeted Drug Delivery for Chronic Nonmalignant Pain: Longitudinal Data From the Product Surveillance Registry as seen in Neuromodulation Journal
Medical articles by Nura physicians
Chronic Pain 101: The Importance of Multimodal Therapy by Cody Foster, MD in Minnesota Physician, March 2023
Chronic Pelvic Pain Management by Erin Bettendorf, MD in Minnesota Physician, October 2022
Drug Delivery Solutions Providers: The One-Stop Clinic for Precision Pain Management by David Schultz, MD in MedTech Outlook, June 2022
Neurostimulation for Chronic Pain by David Schultz, MD in Minnesota Physician, February 2022
Cancer Pain Management by R. Scott Stayner, MD, Ph.D. in Minnesota Physician, August 2021
The MinuteMan: Advances in Spinal Fusion by R. Scott Stayner, MD, Ph.D. in Minnesota Physician, April 2021
Targeted Drug Delivery: Feedback from Patients by David Schultz, MD in Minnesota Physician, May 2020
Dialing Down Opioid Use: Alternative Treatments by David Schultz, MD in Minnesota Physician, April 2019
The Importance of a Pain Management Plan: A Guide for Primary Care Physicians by David Schultz, MD in Minnesota Physician, November 2015
Clinical abstracts & posters
Functional Outcomes for Patients with Lumbar Spinal Stenosis Treated with MinuteMan™ Minimally Invasive Fusion Monotherapy Compared to Combination Therapy with Spinal Cord Stimulation in a Real-World Pain Clinic by R. Scott Stayner, MD, Ph.D. at ASPN ’23
A Rare Case of Anaphylaxis to Intrathecal Fentanyl Citrate: Case Report by Akhila Sridharamurthy, MBBS, MS at Physiatry ’23
Early Experience with Closed-Loop SCS During In-clinic Testing by David Schultz, MD at NANS 2023
Longitudinal Data from the Targeted Drug Delivery (TDD) Product Surveillance by David Schultz, MD at NANS 2023
A Comparison of Pain Relief from Spinal Cord Stimulation between Patients with and without Failed Back Surgery Syndrome by R. Scott Stayner, MD, Ph.D. at INS 2022
Patient Satisfaction Following Intrathecal Targeted Drug Delivery for Benign Chronic Pain Results of a Single-Center Survey Study by David Schultz, MD at CNS 2022
Dorsal Root Ganglion Stimulation Reduces Pain and Improves Physical Function for Causalgia Patients by David Schultz, MD at NANS 2022
DRG Stimulation is an Effective Treatment for Patients with Causalgia of the Lower Extremities by David Schultz, MD at NANS 2022
Current clinical trials
Abbott: Spinal Cord Stimulator (SCS) and Dorsal Root Ganglion (DRG) Systems
- REALITY: Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator: NCT03876054
- ROSTRA: Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation: NCT04873817
Medtronic: Targeted Drug Delivery Systems and Neurostimulator Systems
- ECHO-MDT: Electrically Evoked Compound Action Potentials Human Observation Medtronic System Study
- PROSE: Programming Optimization for Spinal Evoked Compound Action Potentials
- PSR: Product Surveillance Registry: NCT01524276
- SGX Procura: A Post-Market, Observational Clinical Study to Evaluate the Effects of Differential Target Multiplexed DTM™ SCS Programming in Treating Intractable Chronic Upper Extremity Limb Pain: NCT04466111
You could be the one
Find out how you could help advance medicine. Call 952-937-9000 or send an email to research@nuraclinics.com to learn more about participating!